Vincent Pocholle·Apr 21, 2023Iron Hack Case Study 1: Public HospitalsHow might we transform the end-to-end patient’s experience in emergencies of public hospitals?A response icon12A response icon12
Lalit Hira·Mar 27, 2020CURA: open-source design for emergency COVID-19 ICUsRenders: Carlo Ratti Associati
Richard Peter·Oct 22, 2016UK’s Drug Discovery Prospective at Risk, Warns Industry BodyAccording to a report commissioned by the Association of the British Pharmaceutical Industry (ABPI), the membership organization for UK…
Richard Peter·Oct 18, 2016New Medicine for Rare, Chronic Liver DiseaseThe European Medicines Agency (EMA) has suggested conceding a provisional marketing approval in the European Union (EU) to Ocaliva…
Richard Peter·Sep 28, 2016Zika Virus Infection: Plasma- And Urine-Derived Medicines Safe to UsePlasma-derived medicines are prepared from human blood. They are used to treat and prevent serious diseases and include coagulation factors…
Richard Peter·Sep 17, 2016New Treatment for Breast CancerThe European Medicines Agency (EMA) has suggested conceding a marketing endorsement in the European Union (EU) for Ibrance for the…
Richard Peter·Sep 16, 2016Fighting Antimicrobial Resistance GloballyAccording to a meeting between the European Medicines Agency (EMA), the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) and the…
Richard Peter·Sep 7, 2016Better Monitoring of Biological MedicinesThe European Medicines Agency (EMA) has implemented a new section to its guidelines on good pharmacovigilance practices (EU-GVP), named…
Richard Peter·Aug 18, 2016Addressing Challenges of Innovative Cancer Immunotherapy MedicinesThe European Medicines Agency’s (EMA) Committee for Advanced Therapies (CAT) is arranging a workshop on 15 and 16 November 2016 to talk…
Richard Peter·Jul 30, 2016Eu Orphan Status for Cell Medica DrugLondon, UK-based Cell Medica has received European Commission orphan drug designations for its lead cancer immunotherapy CMD-003.
